Callan Capital LLC cut its stake in Relx Plc (NYSE:RELX – Free Report) by 11.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,110 shares of the technology company’s stock after selling 1,044 shares during the quarter. Callan Capital LLC’s holdings in Relx were worth $368,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of RELX. CENTRAL TRUST Co increased its stake in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in shares of Relx in the 4th quarter valued at about $31,000. Sierra Ocean LLC bought a new stake in shares of Relx in the 4th quarter valued at about $43,000. Private Trust Co. NA increased its stake in shares of Relx by 119.9% in the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after acquiring an additional 566 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of Relx in the 3rd quarter valued at about $125,000. 15.02% of the stock is owned by institutional investors.
Relx Price Performance
NYSE RELX opened at $49.29 on Friday. The business has a 50 day simple moving average of $48.13 and a 200 day simple moving average of $47.32. Relx Plc has a 52-week low of $40.25 and a 52-week high of $51.99. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The stock has a market cap of $91.60 billion, a price-to-earnings ratio of 26.50, a PEG ratio of 2.73 and a beta of 0.90.
Relx Increases Dividend
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. StockNews.com cut Relx from a “buy” rating to a “hold” rating in a research note on Saturday. Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They set a “buy” rating for the company.
Read Our Latest Analysis on Relx
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
- Five stocks we like better than Relx
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What Are the U.K. Market Holidays? How to Invest and Trade
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is Insider Trading? What You Can Learn from Insider Trading
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.